Vical and AnGes Collaborate on Late-Stage Cancer Therapy.
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)
Published: 6 Jul-2006
DOI: 10.3833/pdr.v2006.i73.484 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Vical entered into a co-development agreement for its Phase II anticancer therapy Allovectin-7® with Japanese biopharmaceutical company AnGes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS